The release of Semaglutide at a 45mg level represents a important step forward in treating type 2 diabetes. Until recently, smaller doses were usually prescribed, but this additional formulation offers the potential for more effective blood sugar control in many patients. Clinicians are assessing its impact and safety profile, specifically in pa… Read More